FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 1864174 · Received October 11, 2010

Report

Report Number
2124215-2010-15972
Event Type
Injury
Date Received
October 11, 2010
Date of Event
August 4, 2010
Report Date
August 4, 2010
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AVAILABLE INFORMATION SUGGESTS THAT THIS RA LEAD WAS DISCARDED AFTER THE PROCEDURE, AND WILL NOT BE RETURNED TO BOSTON SCIENTIFIC. A REQUEST WAS MADE TO HAVE THE EXPLANTED DEVICE RETURNED. THIS EVENT WILL BE UPDATED IF ANY ADDITIONAL INFORMATION BECOMES AVAILABLE.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) AND TRANSVENOUS RIGHT ATRIAL (RA) LEAD WERE EXPLANTED DUE TO A SYSTEM INFECTION. OF NOTE, A COMPETITIVE RIGHT VENTRICULAR LEAD WAS ALSO EXPLANTED AT THE TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 54 YR Life Threatening| R 4054| T125| E110| 6945| 1853